Trizivir Tablets Recalled Due to Potential Foreign Tablet Contamination
GlaxoSmithKline is recalling Trizivir tablets because they may contain foreign Lexiva tablets. Patients should stop using the affected lot and contact their healthcare provider.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls with potential for significant injury or adverse health consequences (such as ingesting the wrong medication) are classified as Severe (Score 4).
Plain-English summary
GlaxoSmithKline Inc is recalling 14,465 bottles of Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, NDC 49702-217-18. The recall is due to the potential presence of foreign tablets, specifically Lexiva 700 mg tablets, within the bottles.
The affected product is identified by Lot #0ZP5128 with an expiration date of 8/2013. The recall covers a nationwide distribution of the product. Trizivir is a prescription-only medication manufactured for ViiV Healthcare by GlaxoSmithKline.
Patients and healthcare providers should stop using the affected lot of Trizivir and contact their healthcare provider for guidance on alternative treatment options. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
- Manufacturer
- GlaxoSmithKline Inc
- Category
- Drug — Antiretroviral
- Affected units
- 14,465
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #0ZP5128 exp
- 8/2013
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · GlaxoSmithKline Inc
See all →- HighGlaxoSmithKline Recalls Ventolin Inhalers Due to Low Albuterol Content
FDA (Drugs) · 2012-09-05
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02